Control AAV
Key Benefits
-
Stable and reliable fluorescent AAV controls
-
Options for both single-stranded and double-stranded AAVs
-
Titer exceeds 1E+13 GC/ml
-
Suitable for various in vivo or cell culture experiments
-
Double-stranded AAVs exhibit 6 to 15 times faster expression
Products Details
Empty AAV Particles Empty AAV particles are created using only the essential components for AAV replication, such as Rep, Cap, and helper. These particles are completely devoid of any genetic material, resulting in entirely empty capsids. Unlike typical AAV vectors, they do not contain any therapeutic transgene.
| Type | Catalog No. | Promoter and Gene | Serotype | Concentration | QC |
|---|---|---|---|---|---|
| Empty AAV particles | AAVEC001 | Non | AAV2, AAV5, AAV8, AAV9 | 1E13 VP/mL | Endotoxin by LAL＜10EU/mL Purity by SDS-PAGE Capsid titer by ELISA |
| AAVEC002 | Non | AAV6 | 1E13 VP/mL |
Control AAV Control AAV vectors offer a practical solution for researchers conducting gene delivery experiments, including gene therapy, gene editing, and gene regulation. Instead of carrying therapeutic genes, PackGene’s control AAV vectors come in a range of serotypes, promoters, and reporters/transgenes, enabling researchers to select the most appropriate vector for their particular research needs.
| Type | Catalog No. | Promoter and Gene |
|---|---|---|
| No reporter AAV | AAV-EA020 | ssAAV.CAG.WPRE.SV40pA |
| AAV-EC020 | scAAV.CAG.WPRE.SV40pA | |
| AAV-EA040 | ssAAV.CMV.WPRE.SV40pA | |
| Fluorescence | AAV-EA021 | ssAAV.CAG.EGFP.WPRE.SV40pA |
| AAV-EC021 | scAAV.CAG.EGFP.WPRE.SV40pA | |
| AAV-EA041 | ssAAV.CMV.EGFP.WPRE.SV40pA | |
| AAV-EC041 | scAAV.CMV.EGFP.WPRE.SV40pA | |
| AAV-EA022 | ssAAV.CAG.mCherry.WPRE.SV40pA | |
| AAV-EC022 | scAAV.CAG.mCherry.WPRE.SV40pA | |
| AAV-EA042 | ssAAV.CMV.mCherry.WPRE.SV40pA | |
| AAV-C-11723 | scAAV.CMV.mCherry.WPRE.SV40pA | |
| AAV-EB041 | ssAAV.CMV.EGFP.PA48 | |
| AAV-EA191 | ssAAV.CBh.EGFP.WPRE.SV40pA | |
| AAV-EA031 | ssAAV.EF1a.EGFP.WPREs.SV40pA | |
| AAV-EA051B | ssAAV.TBG (669p).EGFP.WPRE.SV40pA | |
| AAV-EA101 | ssAAV.hSyn.EGFP.WPREs.SV40pA | |
| AAV-EA171 | ssAAV.hGFAPS.EGFP.WPREs.SV40pA | |
| AAV-EA411 | ssAAV.miniCMV.EGFP.WPRE.SV40pA | |
| AAV-EA011 | ssAAV.EFS.EGFP.WPRE.SV40pA | |
| AAV-EA042 | ssAAV.CMV.mCherry.WPRE.SV40pA | |
| AAV-EA181 | ssAAV.CTNT.ZsGreen.WPRE.SV40pA | |
| AAV-EA591 | ssAAV.UBC.EGFP.WPRE.SV40pA | |
| AAV-EA361 | ssAAV.Tie1.EGFP.WPRE.SV40pA | |
| AAV-EC011 | scAAV.EFS.EGFP.WPRE.SV40pA | |
| AAV-EA611 | ssAAV.mSP-C promoter.EGFP.WPRE.SV40pA | |
| AAV-EA511 | ssAAV.periostin.EGFP.WPRE.SV40pA | |
| AAV-EA501 | ssAAV.Iba1.EGFP.WPRE.SV40pA | |
| AAV-EB361 | ssAAV.Tie1.EGFP.PA48 | |
| AAV-EA621 | ssAAV.mRPE65.EGFP.WPRE.SV40pA | |
| AAV-EA461 | ssAAV.GfaABC1D.EGFP.WPRE.SV40pA | |
| AAV-EA491 | ssAAV.hICAM2.EGFP.WPRE.SV40pA | |
| AAV-EA102 | ssAAV.hSyn.mCherry.WPRE.SV40pA | |
| AAV-EA071 | ssAAV.Rat Insulin.EGFP.WPRE.SV40pA | |
| AAV-EC028 | scAAV.CAG.GLuc.WPRE.SV40pA | |
| AAV-EA441 | ssAAV.EnSM22α.EGFP.WPRE.SV40pA | |
| AAV-EC051V | scAAV.TBG.EGFP.WPRE.SV40pA | |
| AAV-EC101 | scAAV.hSyn.EGFP.WPRE.SV40pA | |
| AAV-EA391B | ssAAV.MBP(1.9kb).EGFP.WPRE.SV40pA | |
| AAV-EA631 | ssAAV.hBEST1.EGFP.WPRE.SV40pA | |
| AAV-EA026 | ssAAV.CAG.EYFP.WPRE.SV40pA | |
| AAV-EA182 | ssAAV.CTNT.EGFP.WPREs.SV40pA | |
| AAV-EA601 | ssAAV.HCRApoE hAAT.EGFP.WPRE.SV40pA | |
| AAV-EA531 | ssAAV.mALB.EGFP.WPRE.SV40pA | |
| AAV-EC181 | scAAV.CTNT.ZsGreen.WPRE.SV40pA | |
| AAV-C-11592 | ssAAV.SMMHC.EGFP.WPRE.SV40pA | |
| AAV-C-11307 | scAAV.miniCMV.mCherry.WPREs.SV40pA | |
| AAV-C-3199 | ssAAV.CAG.EGFP.NLS.WPRE.SV40pA | |
| Luminesence | AAV-EA029 | ssAAV.CAG.Fluc.WPRE.SV40pA |
| AAV-EA043 | ssAAV.CMV.Fluc.WPRE.SV40pA | |
| AAV-EC028 | scAAV.CAG.Gluc.WPRE.SV40pA | |
| shRNA | AAV-XN09 | scAAV.U6.NCshRNA.CMV.EGFP.WPRE |
| AAV-C-10987 | scAAV.U6.NCshRNA-2.CAG.EGFP.WPRE.SV40pA |